Cost Effectiveness of Aspirin, Clopidogrel, or Both for Seco…

Well Cited

290
Citations
37
Refs
2002
Year
Search Works
Work Details
  • DOI 10.1056/nejm200206063462309
  • PMID https://pubmed.ncbi.nlm.nih.gov/12050341
  • OpenAlex ID W2336413601
  • Type Article
  • Language EN
  • Published 06 Jun 2002
  • Volume 346 (23)
  • Pages 1800–1806
  • Source New England Journal of Medicine
  • Publisher Massachusetts Medical Society
  • FWCI 20.55
  • Countries 3
  • Institutions 5
  • Added 10 Oct 2025
  • Updated 16 Oct 2026
External Links
OpenAlex Record DOI Resolver PubMed PDF
MENU
0

Cost Effectiveness of Aspirin, Clopidogrel, or Both for Secondary Prevention of Coronary Heart Disease

Article 2002 EN Bronze

BACKGROUND: Both aspirin and clopidogrel reduce the rate of cardiovascular events in patients with coronary heart disease. We estimated the cost effectiveness of the increased use of aspirin, clopidogrel, or both for secondary prevention in patients with coronary heart disease. METHODS: We used the Coronary Heart Disease Policy Model, a computer simulation of the U.S. population, to estimate the i…

290

Citations

37

References

7

Authors

20.55

FWCI

Citations by Year
Last 15 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
7 authors
#AuthorInstitutionsORCID
1 Jean‐Michel Gaspoz University Hospital of Geneva (CH) —
2 Pamela G. Coxson University of California, San … (US)
3 Paula A. Goldman Harvard University (US) —
4 Lawrence W. Williams Harvard University (US) —
5 Karen M. Kuntz Harvard University (US)
6 M. G. Myriam Hunink Harvard University (US) Erasmus MC (NL) +1
7 Lee Goldman University of California, San … (US) —
Related Works
10

Data: OpenAlex